The growth in neural technology and cybernetic start-ups will fuel M&A activity between next year and the end of 2025.
Neuralink, a company which is...
Zoltan Istvan to challenge Trump in 2020; solving Longevity is at the top of his agenda.
Last week, the transhumanist activist Zoltan Istvan announced his...
Tandem and Dexcom system aces closed-loop pancreas trial for type 1 diabetes, but doesn't appear to break new ground over existing market competitor.
A clinical...
Cambridge University team release patient test results of insulin pump for artificial pancreas and monitoring device powered by AI.
Of all of the adjectives that...
Risks of leaving a diseased heart in situ are eliminated after US university team's artificial heart breakthrough.
An artificial device implanted in the chest of...
Scientists develop 'blood scrubbing' device capable of filtering out tumorous cells from the bloodstream.
Tumours become deadly when they metastasise, sending cancerous cells through the...
Targeting senescent “zombie” cells may improve cancer survival rates.
How well women with cervical cancer respond to treatment (and survive) correlates with the level of...
We speak to the co-founder of LongeVC – an investment firm focused exclusively on Longevity.
Earlier this month, LongeVC emerged onto the scene with a...
Money can't buy happiness - but it can buy Longevity; this updated report from UBS identifies that investors are re-thinking where they invest their...
![Ozone therapy recently hit the headlines as one of the many treatment options being examined to mitigate the effects of COVID-19 [1], but it is also showing great promise in the treatment of neurodegenerative conditions such as Alzheimer’s and Parkinson's.](https://www.longevity.technology/wp-content/uploads/2020/10/Ozone-therapyW-218x150.jpg "Stopping neurodegeneration in its tracks with ozone therapy")
